CCC
ABT icon

Crescent Capital Consulting’s Abbott ABT Stock Holding History

Crescent Capital Consulting’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$763K Buy
5,420
+5
+0.1% +$640 0.13% 104
2021
Q3 		$640K Sell
5,415
-2,700
-33% -$332K 0.12% 108
2021
Q2 		$941K Sell
8,115
-67
-0.8% -$7.81K 0.18% 84
2021
Q1 		$980K Buy
8,182
+2,203
+37% +$261K 0.21% 81
2020
Q4 		$654K Buy
+5,979
New +$650K 0.17% 88

Other funds holding ABT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Crescent Capital Consulting's ABT Position: Q4 2021 in Review

Crescent Capital Consulting increased its Abbott (ABT) stake by 0.09% in Q4 2021, buying an estimated $640 and bringing the position to 5,420 shares worth $763K. The position accounts for 0.13% of the portfolio, ranked #104.

Crescent Capital Consulting first reported a position in ABT in Q4 2020 and has held it in 5 quarters since. The position peaked at $980K in Q1 2021. 2,812 funds tracked by Wall St. Rank hold ABT as of Q4 2021.

  • Crescent Capital Consulting held 5,420 shares of Abbott worth $763K as of Q4 2021.
  • Crescent Capital Consulting bought 5 Abbott shares in Q4 2021, an estimated $640.
  • Abbott made up 0.13% of Crescent Capital Consulting's portfolio in Q4 2021, its #104 holding.
  • Crescent Capital Consulting first reported a position in Abbott in Q4 2020 and has held it in 5 quarters since.
  • Crescent Capital Consulting's Abbott position peaked at $980K in Q1 2021.
  • 2,812 funds tracked by Wall St. Rank held Abbott as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.